Description A combined vaccine for the prevention of equine influenza (H3N8) and Equine Tetanus. It contains inactivated viral antigens and tetanus toxoid. Aluminum hydroxide is used as an adjuvant, and thiomersal as a preservative.
Target Animals:
Horses
Immunity and Dosage Method of use: injections. Immunity develops within 14-21 days after the second vaccination: